Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Sooma

Explore full profile

Developing, manufacturing and marketing a non-invasive therapy devices for neurological and psychiatric disorders (depression and chronic pain)

Helsinki, FinlandFounded 2013Biotech & Life Sciences
Valuation $10–25M Last recorded · 2024
Revenue $1–10M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Sooma and the history behind them.

About Sooma

Sooma Medical is a healthcare startup focused on providing innovative treatments for depression and chronic pain through brain stimulation therapies. The company operates in the medical technology market and serves a diverse range of clients, including hospitals, clinics, and individual patients. Sooma Medical's therapies are currently utilized in over 30 countries, showcasing their global reach and impact.

The company's business model is centered around the development, production, and distribution of its proprietary brain stimulation devices. These devices are designed to offer a non-invasive, safe, and effective treatment option for psychiatric and neurological disorders. By leveraging scientific research and clinical trials, Sooma Medical ensures that its products meet high standards of efficacy and safety.

Sooma Medical generates revenue through the sale of its brain stimulation devices and associated therapies. The company also offers support and training for healthcare professionals to ensure the optimal use of their products. Additionally, Sooma Medical may engage in partnerships and collaborations with other healthcare providers and research institutions to further expand its market presence and enhance its product offerings.

The company is headquartered in Helsinki, Finland, with its main clinic and production facilities located in the city. Sooma Medical's commitment to high-quality care and its focus on improving the lives of patients suffering from depression and chronic pain are central to its mission and values.

Source: Dealroom company data

At a glance

Founded
2013
Headquarters
Helsinki, Finland
Sector
Biotech & Life Sciences

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

Series A6 investors entered at this stage

  • Italian Angels for Growth
  • Kustaa Piha
  • DOORWAY
  • Voima Ventures
  • Verge HealthTech Fund
  • Stephen Industries
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇫🇮 Finland70.6%
🇩🇪 Germany11.8%
🇮🇹 Italy5.9%
🇫🇷 France5.9%
🇪🇸 Spain5.9%
5 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Sooma on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sooma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.